What does the evidence say about Curcumin Blood Pressure Meta-Analysis?

The current Migaku evidence database contains 1 reusable source document for Curcumin Blood Pressure Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Introduction Hypertension is a major cardiovascular risk factor in individuals with prediabetes and type 2 diabetes (T2D). [Bahari H (2026); evidence level 1] - Pooled results indicated that curcumin/turmeric supplementation significantly reduced SBP (WMD: -2.69 mmHg; 95% CI: -3.84 to -1.55; p 2 = 30.1%) compared to control groups. [Bahari H (2026); evidence level 1] - However, no significant effect was found on DBP (WMD: -1.20 mmHg; 95% CI: -2.84 to 0.44; p = 0.15; I 2 = 84.3%). [Bahari H (2026); evidence level 1] - Curcumin, with its anti-inflammatory and antioxidant properties, has emerged as a potential adjunct therapy, but its effect on blood pressure in this population remains unclear. [Bahari H (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.